Bainbridge Fertilizer Plant Explosion, One Dead

Thursday, August 20th, 2015 at 4:06 pm    

Liquid Transfer Terminals in Bainbridge, Georgia was the site of an explosion on Wednesday morning, August 19, resulting in a fire and massive amounts of black smoke pouring from the plant. Roads around the area were closed until as late as 5 p.m. due to the potential exposure to hazardous chemicals. Neighborhoods close to the plant were evacuated and schools in the area were on lockdown to protect children from exposure.

The explosion reportedly killed one man while he was welding at the top of the plant. The explosion is suspected to have been initiated due to a spark from this welding. Another worker was on his way to relieve the welder from his position when the explosion occurred. The second worker is reportedly uninjured.

The fire was extinguished by 2:30 p.m. on the same day, however, officials kept a diligent watch on the area as smoke continued to flow from the plant as chemicals burned down.

Iowa City organization fundraises to help girl with rare kidney disease

Wednesday, August 19th, 2015 at 3:25 pm    

Twenty-nine-year-old Jenna Smith, who is afflicted with dense deposit disease – a rare kidney ailment – returns twice a year to her hometown in Iowa City, but the journey isn’t easy.

Smith, a graduate of West High School and the University of Iowa, was diagnosed with the disease when she was six years old. Feeling the need to bring awareness to this rare disease, her parents founded a non-profit, Kidneeds, for DDD research. They are now able to grant $50,000 yearly to the cause.

Since her diagnosis, Smith’s father has given her a kidney, which her body rejected soon after the operation. She is now able to manage her disease through an in-home dialysis treatment that she does five times a week.

Our attorneys at Williams Kherkher help victims of pharmaceutical companies who manufacture and sell dangerous drugs like Fresenius Medical Group’s kidney dialysate, GranuFlo. If you or a loved one has been harmed by the GranuFlo medication, call our offices today at (800) 220-9341.

Explosions at Conroe chemical plant cause 3-alarm fire, road closures

Saturday, August 15th, 2015 at 9:47 am    

The first of a series of explosions at the DrillChem chemical plant in Conroe, TX, just north of Houston, occurred at 4:40 pm on Friday, August 14th. These explosions resulted in a massive 3-alarm fire at the plant, with safety officials closing nearby roadways and issuing a shelter in place ordinance for those living within a 2-mile radius of the plant.

A hazmat team from The Woodlands, as well as more than 50 firefighters, responded to the blaze and began fighting the fire at around 6 pm, with the fire coming under control around 6:15 pm. Loop 336 was re-opened by 8:30 pm, and the shelter request was lifted last night.

Authorities worried that there could have been individuals inside or near the plant at the time of the explosion. However, representatives of the company state that the last employee left for the day at 4pm.

Possible causes of bleeding inside the brain

Tuesday, August 11th, 2015 at 3:24 pm    

Intracerebral hemorrhage, or the kind of bleeding that takes place inside the brain, is often linked to high-blood pressure but can also be caused by the following factors:

  • Brain artery blockage
  • Severe head injury or any head damage
  • Bursting blood vessels
  • Abnormal blood flow
  • Abusing substances like cocaine
  • Blood thinner medications
  • Bleeding tumors
  • Some bleeding problems like sickle cell anemia or hemophilia

Though intracerebral hemorrhage may happen to anyone, especially older people, some medical literature has suggested that men are at a higher risk of suffering from this kind of stroke compared to women.

Intracerebral hemorrhage has also been known to happen in those who are medicating with Xarelto. If you or someone you know has experienced any adverse side effects from taking this drug, the skilled pharmaceutical lawyers of Williams Kherkher may work on your behalf for financial compensation from those responsible. Discuss your situation with us today by calling (800) 220-9341, and learn how we may help you recover your losses.

Chemotherapy: A valuable uterine cancer treatment

Friday, August 7th, 2015 at 2:50 pm    

Patients whose endometrial cancer has been diagnosed and treated early on have a better chance of survival and cure. In fact, diagnosing and treating earlier stages of endometrial cancer (stage 0 to stage 2) provide a 5-year survival rate of 69% to 90%. So, at the early stages at least, there are a majority of good outcomes for endometrial cancer patients.

One of the most effective treatment options for endometrial cancer is chemotherapy. Chemotherapy involves the use of a combination of drugs to fight against cancer. Because these cancer-fighting drugs reach throughout the body, chemotherapy is an effective treatment for endometrial cancer that has already spread beyond the uterus and the pelvic area.

Hysterectomies utilizing power morcellators have been found to increase the risk of spreading undetected uterine cancer. If you have been harmed by this device, you might be eligible to file a claim against the manufacturer of this product. To learn more about seeking compensation, consult with our power morcellator legal team at Williams Kherkher by calling (800) 220-9341 today.

GSK accused of illegal marketing of Zofran

Friday, August 7th, 2015 at 2:46 pm    

A mother whose son was born with congenital defects in his lungs and heart has filed a case against GlaxoSmithKline (GSK) claiming that the company marketed its anti-nausea drug Zofran for conditions other than what it was approved to treat – namely morning sickness, a report by the Louisiana Record stated on July 20.

The plaintiff alleges that the company promoted its drug for morning sickness when it was only approved to treat severe nausea caused by radiation and chemotherapy treatments. The suit, which was filed in the U.S. District Court of the Eastern District of Louisiana, also alleges that the mother’s use of Zofran from her first to third trimester caused her baby to develop birth defects.

The complainant seeks damages beyond the court’s limit of $75,000, plus a full refund of Zofran purchases and other fees.

If you believe taking Zofran has caused your baby to develop congenital defects, you might be eligible to seek damages from the offending pharmaceutical company. Speak with our Zofran legal team at Williams Kherkher by calling (800) 220-9341 to learn more about taking legal action.

Radiation therapy for uterine cancer

Friday, August 7th, 2015 at 1:41 pm    

Uterine cancer is considered among the deadliest types of cancer affecting women. In fact, the American Cancer Society predicts that this year, about 10,170 women will die from uterine cancer complications. The agency also said approximately 54,870 women will be diagnosed with the disease.

One of the most common endometrial cancer treatments is radiation therapy. Radiation therapy involves the use of radiation to kill cancer cells and can be performed using a machine outside the body (external beam radiation), or a radiation-filled device placed inside the body (brachytherapy). However, people undergoing radiation therapy for uterine cancer may experience some side-effects, such as rectal bleeding, bladder irritation, incontinence, and sexual problems.

Some studies showed that the risk of uterine cancer is higher among women who have undergone laparoscopic procedure involving a power morcellator. If this device has caused you harm, you might be eligible to seek compensation from the manufacturer involved. Speak with our team at Williams Kherkher by calling (800) 220-9341 today to learn more about filing a lawsuit.

Am I taking drugs off label?

Friday, August 7th, 2015 at 10:28 am    

Until 2006, the U.S. Food and Drug Administration (FDA) did not allow Janssen Pharmaceutical to market its atypical anti-psychotic drug Risperdal for use in children due to lack of evidence that the drug is safe for pediatric use. However, a 1994 product outline revealed that the company planned to promote the drug for off-label use in children, causing the company to be involved in many lawsuits.

The use of a drug for conditions other than what it is approved for can be risky. Because doctors have no duty to disclose to their patients whether they are receiving an off label prescription or not, you should ask your doctor right away if you are receiving drugs off label. If so, ask them about how sure they are about prescribing you the drug, and how certain they are that you will benefit from it.

Some drug companies engage in unfair practices, such as selling their products for unapproved uses at consumers’ expense. If you think Risperdal has harmed you or your loved one, speak with an attorney at Williams Kherkher by calling (800) 220-9341 to learn more about taking legal action against the pharmaceutical company involved.

High risk factors for hematuria

Wednesday, August 5th, 2015 at 9:46 am    

Hematuria, or the presence of blood in the urine, may possibly occur in anyone regardless of age. However, the following people are at high risk of suffering symptoms of hematuria:

  • Hematuria may occur in older men with an expanded prostate gland.
  • Hematuria may occur in those with a family history of kidney problems.
  • Women who suffer urinary tract infection (UTI) are at risk of hematuria symptoms.
  • People with kidney infections.
  • Younger males who have kidney problems, like alport syndrome, may notice blood in their urine.
  • Hematuria may also occur in those who are involved in too much physical activity, like long-distance running.
  • Some medications, like pain relievers, antibiotics and aspirin, may possibly cause hematuria.

People who take Xarelto, an anticoagulant, are also at high risk of suffering from symptoms similar to hematuria that can be serious and even fatal. If you or a loved one has experienced this, the legal team of Williams Kherkher may work for you to pursue damage claims from irresponsible pharmaceutical companies. Find out how we may help you recover your loss today by calling (800) 220-9341.

Robotically assisted technology increases number of hip/knee replacements

Saturday, August 1st, 2015 at 11:27 am    

Doctors and hospitals all over the United States have been attesting to the fact that operations for knee and hip replacements have been on the rise lately, thanks mostly in part to robotically-assisted surgery. This technology is much-needed, considering the country is home to 40-50 million Americans suffering from a debilitating form of arthritis or other joint-related diseases.

Dr. Michael Ast, the medical director of the Robotic Joint Replacement Program at Robert Wood Johnson University Hospital Hamilton, said doctors in the U.S. have been performing around 1 million to 1 ½ million knee and hip implant operations every year. This number is forecasted to triple by 2025. As baby boomers and their children continue to age, a third of the United States population is projected to be over 50 years of age by 2030.

Our attorneys at the Williams Kherkher Law Firm in Houston are committed to defending your legal rights. If your health or well-being has been compromised by a defective DePuy hip implant, do not hesitate to get in touch with us by calling our offices today at (800) 220-9341.

1 2 3 46
The Search Engine Guys